Axel Bolte

Insider Reports History

Entity
Individual
Location
Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ
Signature
/s/ Sanjay Subramanian, as attorney-in-fact for Axel Bolte
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Axel Bolte:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inozyme Pharma, Inc. Director Stock Option (right to buy) 28K Jun 18, 2024 Direct
IVERIC bio, Inc. Director Common Stock 0 $39.45 Jul 11, 2023 Direct
IVERIC bio, Inc. Director Restricted Stock Units 0 Jul 11, 2023 Direct
IVERIC bio, Inc. Director Stock Option (Right to Buy) 0 $10.03 Jul 11, 2023 Direct

Insider Reports Filed by Axel Bolte

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INZY Inozyme Pharma, Inc. Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
ISEE IVERIC bio, Inc. Jul 11, 2023 8 $0 4 Jul 13, 2023 Director
INZY Inozyme Pharma, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
ISEE IVERIC bio, Inc. May 17, 2023 1 $0 4 May 19, 2023 Director
ISEE IVERIC bio, Inc. May 11, 2023 2 $0 4 May 15, 2023 Director
INZY Inozyme Pharma, Inc. May 1, 2023 1 $0 4 May 3, 2023 Director
INZY Inozyme Pharma, Inc. Mar 31, 2023 1 $10.6K 4 Apr 4, 2023 Director
INZY Inozyme Pharma, Inc. Sep 30, 2022 1 $7.56K 4 Oct 4, 2022 Chief Executive Officer, Director
ISEE IVERIC bio, Inc. May 11, 2022 4 $0 4 May 13, 2022 Director
INZY Inozyme Pharma, Inc. Apr 19, 2022 1 $250K 4 Apr 20, 2022 Chief Executive Officer, Director
INZY Inozyme Pharma, Inc. Feb 24, 2022 1 $0 4 Feb 28, 2022 Chief Executive Officer, Director
INZY Inozyme Pharma, Inc. Jun 24, 2021 3 $65.4K 4 Jun 25, 2021 Chief Executive Officer, Director
ISEE IVERIC bio, Inc. May 19, 2021 2 $0 4 May 20, 2021 Director